Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Charles T Moerk

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Journal of Biomedical Materials Research. Part A|January 26, 2018
Regulation of skeletal myotube formation and alignment by nanotopographically controlled cell-secreted extracellular matrixAlex Jiao, Charles T Moerk, Nisa Penland, et al.
Journal of Visualized Experiments : Jove|April 24, 2023
Preclinical Drug Testing in Scalable 3D Engineered Muscle TissuesBonnie J Berry, Shawn M Luttrell, Charles T Moerk, et al.
Alzheimer'S & Dementia (New York, N. Y.)|April 27, 2022
AD Informer Set: Chemical tools to facilitate Alzheimer's disease drug discoveryFrances M Potjewyd, Joel K Annor-Gyamfi, Jeffrey Aubé, et al.
Alzheimer'S & Dementia (New York, N. Y.)|April 18, 2022
Use of AD Informer Set compounds to explore validity of novel targets in Alzheimer's disease pathologyFrances M Potjewyd, Joel K Annor-Gyamfi, Jeffrey Aubé, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Journal of Biomedical Materials Research. Part A|January 26, 2018
Regulation of skeletal myotube formation and alignment by nanotopographically controlled cell-secreted extracellular matrixAlex Jiao, Charles T Moerk, Nisa Penland, et al.
Journal of Visualized Experiments : Jove|April 24, 2023
Preclinical Drug Testing in Scalable 3D Engineered Muscle TissuesBonnie J Berry, Shawn M Luttrell, Charles T Moerk, et al.
Alzheimer'S & Dementia (New York, N. Y.)|April 27, 2022
AD Informer Set: Chemical tools to facilitate Alzheimer's disease drug discoveryFrances M Potjewyd, Joel K Annor-Gyamfi, Jeffrey Aubé, et al.
Alzheimer'S & Dementia (New York, N. Y.)|April 18, 2022
Use of AD Informer Set compounds to explore validity of novel targets in Alzheimer's disease pathologyFrances M Potjewyd, Joel K Annor-Gyamfi, Jeffrey Aubé, et al.
Pageof 1